
    
      patients with high risk for ovarian hyperstimulation will undergo a freeze-all protocol then
      montelukast & dydrgesteron will be given to cases with suspected or proven ovarian
      hyperstimulation in one group in comparison with dydrogesteron alone in the other group.
    
  